Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
14.90
+0.21 (1.43%)
Oct 4, 2024, 4:00 PM EDT - Market closed
Assembly Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -45.61 | -61.23 | -93.09 | -129.86 | -62.15 | -97.63 | Upgrade
|
Depreciation & Amortization | 0.26 | 0.45 | 0.5 | 0.47 | 5.91 | 4.95 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.14 | 0.14 | - | -1.38 | 0.01 | 0.1 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | 41.64 | 1.75 | - | Upgrade
|
Loss (Gain) From Sale of Investments | -3.59 | -1.59 | 0.16 | 0.59 | -0.01 | -1.74 | Upgrade
|
Stock-Based Compensation | 3.67 | 5.12 | 6.59 | 5.24 | 21.85 | 20.56 | Upgrade
|
Other Operating Activities | 2.51 | 3.51 | 3.51 | 1.31 | - | -0.78 | Upgrade
|
Change in Accounts Receivable | 0.34 | 0.9 | -0.61 | 0.89 | 2.14 | -0.94 | Upgrade
|
Change in Accounts Payable | -0.1 | -2.03 | -0.17 | -1.94 | 2.87 | -1.96 | Upgrade
|
Change in Unearned Revenue | 69.24 | 83.56 | - | -6.25 | -28.06 | -3.61 | Upgrade
|
Change in Other Net Operating Assets | -2.53 | -6.09 | -1.35 | -4.1 | -7.26 | -3.01 | Upgrade
|
Operating Cash Flow | 24.33 | 22.74 | -84.46 | -93.4 | -62.96 | -84.07 | Upgrade
|
Capital Expenditures | -0.24 | -0.26 | -0.1 | -3.1 | -0.47 | -1.55 | Upgrade
|
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 1.5 | 2.36 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | - | -1.75 | - | Upgrade
|
Investment in Securities | -48.18 | -68.91 | 89.24 | 27.25 | 70.29 | -48.76 | Upgrade
|
Investing Cash Flow | -48.39 | -69.14 | 90.64 | 26.52 | 68.07 | -50.32 | Upgrade
|
Issuance of Common Stock | 21.65 | 13.82 | 0.61 | 53.06 | 7.6 | 139.65 | Upgrade
|
Financing Cash Flow | 21.65 | 13.82 | 0.61 | 53.06 | 7.6 | 139.65 | Upgrade
|
Net Cash Flow | -2.42 | -32.58 | 6.79 | -13.82 | 12.71 | 5.26 | Upgrade
|
Free Cash Flow | 24.1 | 22.49 | -84.57 | -96.49 | -63.43 | -85.62 | Upgrade
|
Free Cash Flow Margin | 112.18% | 313.95% | - | -1542.88% | -80.18% | -536.37% | Upgrade
|
Free Cash Flow Per Share | 4.63 | 4.91 | -20.96 | -26.75 | -21.48 | -39.13 | Upgrade
|
Levered Free Cash Flow | 5.5 | -8.2 | -48.91 | -62.75 | -10.96 | -42.72 | Upgrade
|
Unlevered Free Cash Flow | 5.5 | -8.2 | -48.91 | -62.75 | -10.96 | -42.72 | Upgrade
|
Change in Net Working Capital | -33.39 | -26.89 | -2.23 | 7.6 | -0.43 | 1.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.